← All stocks

PALVELLA THERAPEUTICS, INC.

PVLA Net selling
CIK 0001583648 #2032 in the set updated 17 Sep 2026
Bought (120 mo)
$1.56M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$34.92M
$4.17M on a plan · $6.01M straight out of an exercise
Sold at will
$24.75M
8 of 54 sales
Net
−$33.36M
−$23.19M against sales at will

By person

13 insiders · 73 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ORBIMED ADVISORS LLC entity
10% owner
$19.83M (8)
−$19.83M
38,870
$5.88M
−98.6%
Aquilo Capital Management, LLC entity
10% owner
$5.61M (1)
−$5.61M
3,675,530
$556.20M
−34.1%
Goin Kathleen
Chief Operating Officer
$4.85M (30) scheduled
−$4.85M
0
$0.00
JENKINS GEORGE M
Director
$702.49K (5)
$4.17M (9) scheduled
−$3.46M
187,148
$28.32M
−7.0%
Reine Allan
Chief Financial Officer
$313.35K (2)
+$313.35K
65,000
$9.84M
HERON ELAINE J
Director
$300.00K (1)
+$300.00K
47,812
$7.24M
+5.3%
BVF PARTNERS L P/IL entity
See Explanation of Responses
$224.97K (3)
−$224.97K
38,961
$5.90M
−99.2%
Olwill Shane
Chief Development Officer
$196.38K (2) scheduled
−$196.38K
4,638
$701.85K
0.0%
GERAGHTY JAMES A
Director
$105.70K (3)
+$105.70K
20,000
$3.03M
ADAR1 Capital Management, LLC entity
10% owner
$92.33K (3)
+$92.33K
15,067
$2.28M
+66.2%
KIRITSY CHRISTOPHER P
Director
$34.03K (2)
$49.14K (1) scheduled
−$15.12K
250
$37.83K
Demuth Tim
Chief Medical Officer
$10.26K (1)
+$10.26K
6,000
$907.96K
Korenberg Matthew E
CFO, Treasurer
1,000
$151.33K

No percentages here. This company's share count has moved by a factor of 10.9 over the window, from 1,320,240 to 14,408,407 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
JENKINS GEORGE M
30 Mar 2026
Director
Buy
445
$112.30
$49.97K
HERON ELAINE J
27 Feb 2026
Director
Buy
2,400
$125.00
$300.00K
JENKINS GEORGE M
27 Feb 2026
Director
Buy
4,000
$125.00
$500.00K
JENKINS GEORGE M
9 Apr 2025
Director
Buy indirect
2,490
$20.27
$50.47K
JENKINS GEORGE M
9 Apr 2025
Director
Buy
2,500
$20.13
$50.33K
JENKINS GEORGE M
18 Dec 2024
Director
Buy
4,000
$12.93
$51.72K
ADAR1 Capital Management, LLC
12 Aug 2024
10% owner
Buy indirect
757
$15.88
$12.02K
ADAR1 Capital Management, LLC
12 Aug 2024
10% owner
Buy indirect
2,243
$15.88
$35.62K
ADAR1 Capital Management, LLC
9 Aug 2024
10% owner
Buy indirect
3,000
$14.89
$44.68K
GERAGHTY JAMES A
7 Aug 2024
Director
Buy
1
$1.00
$1.00
KIRITSY CHRISTOPHER P
25 May 2023
Director
Buy
10,000
$0.85
$8.50K
Demuth Tim
13 May 2022
Chief Medical Officer
Buy
6,000
$1.71
$10.26K
KIRITSY CHRISTOPHER P
14 Sep 2018
Director
Buy
5,000
$5.11
$25.53K
GERAGHTY JAMES A
15 May 2018
Director
Buy
10,000
$5.75
$57.50K
Reine Allan
17 Aug 2017
See Remarks
Buy
20,000
$4.89
$97.80K
GERAGHTY JAMES A
17 Aug 2017
Director
Buy
10,000
$4.82
$48.20K
Reine Allan
16 Aug 2017
See Remarks
Buy
45,000
$4.79
$215.55K

What was left out

Form 4 filings counted 177
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 37
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 5,682,195
Sales filed before the plan box existed 8
History held since 22 Sep 2016